Anki Malmborg Hager

Directeur/Membre du Conseil chez SENZAGEN AB

Profil

Cecilia Ann-Christin Malmborg Hager is currently the Chief Executive Officer & Director at Pain Drainer AB since 2019.
She is also a Non-Independent Director at SenzaGen AB since 2014.
Additionally, she holds director positions at Diaprost AB, Hager Consulting AB, Avena Partners AB, Nanoecho AB, Colzyx AB, and Lead Biologics International AB.
In her former roles, Dr. Malmborg Hager served as the Chief Executive Officer at WC Likvid AB.
She was also the Chief Executive Officer & Director at Cantargia AB from 2013 to 2014.
She held the position of Chief Executive Officer at Sista versen 26366.
AB and Executive Foundation Lund.
Furthermore, she was the Chief Executive Officer at Xlmmune AB.
Prior to that, she worked as an Investment Director at Lund University Bioscience AB from 2009 to 2011.
She also served as an Independent Director at Immunovia AB and as a Director & Business Manager at ProNoxis AB.
Additionally, she held director positions at Bulb Intelligence AB and served as the Vice President-Business Development at Alligator Bioscience AB.
Dr. Malmborg Hager obtained her graduate and doctorate degrees from the University of Lund.

Postes actifs de Anki Malmborg Hager

Sociétés	Poste	Début
SENZAGEN AB	Directeur/Membre du Conseil	17/06/2019
Hager Consulting AB	Directeur/Membre du Conseil	-
Nanoecho AB	Directeur/Membre du Conseil	-
Pain Drainer AB	Directeur Général	01/09/2019
Avena Partners AB	Directeur/Membre du Conseil	-
Diaprost AB	Directeur/Membre du Conseil	-
Colzyx AB	Directeur/Membre du Conseil	-

Anciens postes connus de Anki Malmborg Hager

Sociétés	Poste	Fin
Lund University Bioscience AB	Directeur en chef des Investissements	-
ProNoxis AB	Directeur/Membre du Conseil	-
░░ ░░░░░░ ░░	░░░░░░░░░	░░░░░░░░░░
░░░░░ ░░░░░░ ░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░	-
░░░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░

Formation de Anki Malmborg Hager

University of Lund

Doctorate Degree